CorMedix (CRMD) Return on Capital Employed (2011 - 2025)
CorMedix (CRMD) reported Return on Capital Employed of 24.44% for Q4 2025, up 5917.0% on a YoY basis from 0.41% in Q4 2024, and down 13.45% sequentially from 28.24% in Q3 2025.
CorMedix (CRMD) Return on Capital Employed (2011 - 2025) Analysis & Trends
CorMedix (CRMD) has 13 years of Return on Capital Employed data on file, last reported at 24.44% in Q4 2025.
- For the quarter ending Q4 2025, Return on Capital Employed rose 5917.0% year-over-year to 24.44%; the trailing twelve-month figure through Dec 2025 stood at 24.44% (up 5917.0% YoY), and the FY2025 full-year result was 50.34%, up 8391.0% from the prior year.
- Return on Capital Employed fell to 24.44% in Q4 2025, from 28.24% in the prior quarter.
- In the past five years, Return on Capital Employed ranged from a high of 29.12% in Q2 2025 to a low of 112.32% in Q2 2024.
- A 5-year average of 43.29% and a median of 48.43% in 2022 frame the typical range for Return on Capital Employed.
- Across the five-year window, Return on Capital Employed sank 4101 bps in 2024 and jumped 14143 bps in 2025, its largest moves.
- Tracing CRMD's Return on Capital Employed over 5 years: stood at 44.05% in 2021, then slipped by 25 bps to 54.93% in 2022, then retreated by 18 bps to 64.98% in 2023, then jumped by 47 bps to 34.73% in 2024, then jumped by 170 bps to 24.44% in 2025.
- Business Quant data shows CRMD's Return on Capital Employed at 24.44% in Q4 2025, 28.24% in Q3 2025, and 29.12% in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -31.80% |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 10.46% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -68.47% |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 21.10% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 10.19% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -68.84% |
| 10 | CorMedix | 546.82 Mn | 391.62 Mn | 107.31 Mn | 24.44% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 24.44% |
| Sep 30, 2025 | 28.24% |
| Jun 30, 2025 | 29.12% |
| Mar 31, 2025 | 14.50% |
| Dec 31, 2024 | -34.73% |
| Sep 30, 2024 | -103.63% |
| Jun 30, 2024 | -112.32% |
| Mar 31, 2024 | -83.42% |
| Dec 31, 2023 | -64.98% |
| Sep 30, 2023 | -62.62% |
| Jun 30, 2023 | -75.22% |
| Mar 31, 2023 | -61.84% |
| Dec 31, 2022 | -54.93% |
| Sep 30, 2022 | -50.15% |
| Jun 30, 2022 | -51.77% |
| Mar 31, 2022 | -46.71% |
| Dec 31, 2021 | -44.05% |
| Sep 30, 2021 | -38.05% |
| Jun 30, 2021 | -32.46% |
| Mar 31, 2021 | -45.22% |